AngioDynamics, Inc. (NASDAQ: ANGO) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $483M. The Maz Rating grades it against the other companies in its sector.
AngioDynamics, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $11.49, AngioDynamics, Inc. trades at 1.5x sales and 2.9x book value. Over the last twelve months it generated about $327M of revenue and a net loss of $33M. It runs a gross margin of 55.7%, an operating margin of -11.2% and a net margin of -10.1%. It shows return on equity of -19.2%, return on invested capital of -19.9% and a free cash flow yield of 0.3%. On the balance sheet: a debt-to-equity ratio of 0.07 and a current ratio of 2.40. Over the past 52 weeks the share price ranged from $9.39 to $16.29, with a beta of 0.28.
AngioDynamics, Inc. does not currently pay a dividend.
11 Wall Street analyst ratings cover the stock: 5 Buy and 6 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.